Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 3 I, 1997, Pages 951-958

  Laitinen, Annika ^b   Altraja, Alan ^b   Kämpe, Mary ^b   Linden, Margaretha ^b   Virtanen, Ismo ^b   Laitinen, Lauri A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN; TENASCIN;

ADULT; ARTICLE; ASTHMA; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEASONAL VARIATION; STEROID THERAPY;

EID: 0030870119     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.3.9610084     Document Type: Article

References (35)

1. Laitinen, L. A., M. Heino, A. Laitinen, T. Kava, and T. Haahtela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131:599-606.
2. Roche, W. R., R. Beasley, J. H. Williams, and S. T. Holgate. 1989. Sub-epithelial fibrosis in the bronchi of asthmatics. Lancet 1:520-524.
3. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
4. Trigg, C. J., N. D. Manolitsas, J. Wang, M. A. Calderon, A. McAulay, S. E. Jordan, M. J. Herdman, N. Jhalli, J. M. Duddle, S. A. Hamilton, J. L. Devalia, and R. J. Davies. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
5. Lundgren, R., M. Söderberg, S. Hörstedt, and R. Stenling. 1988. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur. Respir. J. 1:883-889.
6. Jeffery, P. K., R. W. Godfrey, E. Ädelroght, F. Nelson, A. Rogers, and S.-Å. Johansson. 1992. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am. Rev. Respir. Dis. 145:890-899.
7. Merker, H.-J. 1994. Morphology of the basement membrane. Microsc. Res. Tech. 28:95-124.
8. Virtanen, I., A. Laitinen, T. Tani, P. Pääkkö, L. A. Laitinen, R. E. Burgeson, and V.-P. Lehto. 1996. Differential expression of laminins and their integrin receptors in developing and adult human lung. Am. J. Respir. Cell Mol. Biol. 15:184-196.
9. Altraja, A., A. Laitinen, I. Virtanen, M. Kämpe, B. G. Simonsson, S.-E. Karlsson, L. Håkansson, P. Venge, H. Sillatsu, and L. A. Laitinen. 1996. Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am. J. Respir. Cell Mol. Biol. 15:482-488.
10. Roman, J., and J. A. McDonald. 1997. Fibronectins. In R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, editors. The Lung: Scientific Foundations, 2nd ed. Lippincott-Raven Publishers, Philadelphia. 737-755.
11. Chiquet-Ehrismann, R., E. J. Mackie, C. A. Pearson, and T. Sakakura. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139.
12. Vartio, T., L. Laitinen, O. Närvänen, M. Cutolo, L.-E., Thornell, L. Zardi, and I. Virtanen. 1987. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J. Cell Sci. 88:419-430.
13. Erickson, H. P. 1993. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5:869-876.
14. Zhao, Y., and S. L. Young. 1995. Tenascin in rat lung development: in situ localization and cellular sources. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13):L482-L491.
15. Koch, M., B. Wehrle-Haller, S. Baumgartner, J. Spring, D. Brubacher, and M. Chiquet. 1991. Epithelial synthesis of tenascin at tips of growing bronchi and graded accumulation in basement membrane and mesenchyme. Exp. Cell Res. 194:297-300.
16. Weinacker, A., R. Ferrando, M. Elliot, J. Hogg, J. Balmes, and D. Sheppard. 1995. Distribution of integrins avβ6 and a9β1 and their known ligands, fibronectin and tenascin, in human airways. Am. J. Respir. Cell Mol. Biol. 12:547-557.
17. Wallace, W. A. H., S. E. M. Howie, D. Lamb, and D. M. Salter. 1995. Tenascin immunoreactivity in cryptogenic fibrosing alveolatis. J. Pathol. 175:415-420.
18. Kaarteenaho-Wiik, K., T. Tani, R. Sormunen, Y. Soini, I. Virtanen, and P. Pääkkö. 1996. Tenascin immunoreactivty as a prognostic marker in usual interstitial pneumonia. Am. J. Respir. Crit. Cure Med. 154:511-518.
19. Raghow, R. 1994. The role of extracellular matrix in post inflammatory wound healing and fibrosis. FASEB J. 8:823-831.
20. Mackie, E. J., W. Halfter, and D. Liverani. 1988. Induction of tenascin in healing wounds. J. Cell Biol. 107:2757-2767.
21. Fässler, R., T. Sasaki, R. Timpl, M.-L. Chu, and S. Werner. 1996. Differential regulation of fibulin, Tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp. Cell Res. 222:111-116.
22. Aas, K. 1981. Heterogeneity of bronchial asthma: sub-populations or different stages of the disease. Allergy 36:3-14.
23. Sovijärvi, A. R. A., L. P. Malmberg, K. Reinikainen, P. Rytilä, and H. Poppius. 1993. A dosimetric method with controlled tidal breathing for histamine challenge: repeatability and distribution of bronchial reactivity in a clinical material. Chest 104:164-170.
24. Workshop Summary and Guidelines. 1991. Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. 1991. J. Allergy Clin. Immunol. 38:808-814.
25. Balza, E., A. Siri, M. Ponassi, F. Caocci, A. Linnala, I. Virtanen, and L. Zardi. 1993. Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett. 332:39-43.
26. Carnemolla, B., A. Leprini, G. Allemani, M. Saginati, and L. Zardi. 1992. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J. Biol. Chem. 267:24689-24692.
27. Matsuura, H., T. Green, and S.-I. Hakomori. 1989. An α-N-acetyl-galactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin. J. Biol. Chem. 264:10472.
28. Linnala, A., V. Kinnula, L. A. Laitinen, V.-P. Lehto, and I. Virtanen. 1995. Transforming growth factor-β regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 13:578-585.
29. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1993. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147:697-704.
30. Roberts, C., T. Birkenmeier, J. McQuillan, S. Akiyama, S. Yamada, W.-T. Chen, K. Yamada, and J. McDonald. 1988. Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the fibronectin receptor by cultured human lung fibroblasts. J. Biol. Chem. 263:4586-4592.
31. Sheppard, D., D. Cohen, A. Wang, and M. Bush. 1992. Transforming growth factor β differentially regulates expression of integrin subunits in guinea pig airway epithelial cells. J. Biol. Chem. 267:1709-1714.
32. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvaaarez-Noon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human lymphocytes and its potential role in regulation of T cell growth. J. Exp. Med. 163:1037-1050.
33. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised double-blind, parallel-group controlled study. J. Allergy Clin. Immunol. 90:32-42.
34. Haahtela, T., M. Järvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, K. Reinikainen, O. Selroos, A. Sovijärvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
35. Ekblom, M., R. Fässler, R. Tomasini-Johansson, K. Nilsson, and P. Ekblom. 1993. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and fibroblasts. J. Cell Biol. 123:1037-1045.